TABLE 1.
Variable | Value |
---|---|
No. of patients | 38 |
Mean age, yrs | 8.0 ± 7.2 |
Sex | |
Female | 26 (68.4) |
Male | 12 (31.6) |
Lesion pathology | |
Ependymoma | 3 (7.9) |
Pilocytic astrocytoma | 5 (13.2) |
Pilomyxoid astrocytoma | 1 (2.6) |
Diffuse astrocytoma | 1 (2.6) |
Glioblastoma | 1 (2.6) |
Medulloblastoma | 9 (23.7) |
Schwannoma | 2 (5.3) |
Ganglioglioma | 2 (5.3) |
ATRT | 2 (5.3) |
Germinoma | 2 (5.3) |
PNET | 2 (5.3) |
Neuroblastoma | 2 (5.3) |
Other* | 6 (15.8) |
Primary site of disease | |
Cerebrum | 4 (10.5) |
Posterior fossa | 14 (36.8) |
Spine vertebrae | 3 (7.9) |
Spinal cord | 12 (31.6) |
Other† | 5 (13.2) |
ATRT = atypical teratoid rhabdoid tumor; PNET = primitive neuroectodermal tumor.
Values are expressed as mean ± standard deviation or number of patients (%).
Other lesion pathologies include optic pathway glioma, neuroblastoma, neurocutaneous melanosis, choroid plexus carcinoma, meningioma, pineoblastoma, and benign lymphovascular lesion.
Other sites include optic chasm, lateral ventricle, pituitary stalk, and pineal gland.